Skip to content

Clinical trials

Phase 2 Stroke trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 2 Country / region: Belgium Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20041
20052
20061
20141
20171
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Inc1
Bayer1
Bioxodes S.A.1
Daiichi Sankyo1
GlaxoSmithKline1
Géraldine Martens1
Melbourne Health1
PAION Deutschland GmbH1
ThromboGenics1
Universitaire Ziekenhuizen KU Leuven1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke11
Ischemic Stroke5
Inflammation2
Atherosclerosis1
Atrial Fibrillation1
Brain Injuries1
Carotid Artery Diseases1
Carotid Stenosis1
Central Nervous System Diseases1
Cerebral Hemorrhage1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.